| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 354 | 89 |
-
| | Cost of Revenue | 116 | 35 |
-
| | | Gross Profit | 238 | 54 |
-
| | | Operating Expenses | | Research Development | 3,665 | 2,670 | 2,870 | | Selling General and Administrative | 26,066 | 19,307 | 12,842 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (29,493) | (21,923) | (15,712) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,842 | 4,048 | 300 | | Earnings Before Interest And Taxes | (27,651) | (17,875) | (15,412) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (27,651) | (17,875) | (15,412) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest | 7,650 | 4,075 | 477 | | | | Net Income From Continuing Ops | (20,001) | (13,800) | (14,935) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (20,001) | (13,800) | (14,935) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,001) | ($13,800) | ($14,935) |
|
0.22% Nasdaq 
0.02 (5.41%) 
Income Statement
